
|Articles|July 27, 2019
ASRS 2019 Street Team: David S. Boyer, MD
Author(s)Ophthalmology Times Staff Reports
David S. Boyer, MD, notes that the goal is to dry every patient out, with undertreatment the leading cause of a loss of visual acuity.
Advertisement
David S. Boyer, MD, shares the take-home message from the presentation he delivered at the 2019 meeting of the American Society of Retina Specialists, "The Average Patient Does Not Enter Your Office: What Can We Learn About Treating nAMD From Individual Patient Responses."
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
2
Oku Digital Health launches from Topcon to link eye care, primary care
3
EURETINA 2026: Optogenetic therapy MCO-010 aims to restore vision in advanced macular disease
4
EURETINA 2026: Eyestem interim Phase 2 results for clinical study of Eyecyte-RPE for GA secondary to dry AMD
5



















